Shanghai Fosun Pharmaceutical Group begins bookbuilding for an Rmb3 billion ($471 million) domestic bond issue on Wednesday, hoping to take advantage of new liquidity flooding into the financial system following the central’s bank surprise cut to banks’ reserve requirement ratio (RRR) on Monday.
¬ Haymarket Media Limited. All rights reserved.
